Agata Hogendorf

Title: Agata Hogendorf: Innovator in Serotonin Receptor Research

Introduction

Agata Hogendorf is a prominent inventor based in Cracow, Poland. She has made significant contributions to the field of pharmacology, particularly in the development of new therapeutic compounds. Her work focuses on serotonin receptors, which play a crucial role in various neurological functions.

Latest Patents

Agata Hogendorf holds a patent for "Imidazolyl-substituted indole derivatives binding 5-HT7 serotonin receptor and pharmaceutical compositions thereof." This invention relates to a new class of substituted indole derivatives that are capable of activating the 5-HT serotonin receptor. These compounds exhibit high affinity and selectivity for the receptor while possessing favorable physicochemical properties. Notably, they are the first described low-basicity 5-HT receptor agonists. The invention also encompasses the use of these compounds in the treatment or prevention of 5-HT receptor-related disorders, particularly those affecting the central nervous system. Additionally, it includes isotopically labeled compounds for in vivo diagnostics or imaging of the 5-HT serotonin receptor.

Career Highlights

Agata is affiliated with the Institute of Pharmacology of the Polish Academy of Sciences, where she conducts her research. Her innovative work has garnered attention in the scientific community, contributing to advancements in pharmacological therapies.

Collaborations

Agata collaborates with notable colleagues, including Adam Hogendorf and Grzegorz Satala, who contribute to her research endeavors.

Conclusion

Agata Hogendorf's contributions to serotonin receptor research and her innovative patent highlight her role as a leading inventor in pharmacology. Her work has the potential to impact the treatment of various neurological disorders significantly.